Viewing Study NCT07129018


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2025-12-26 @ 3:54 AM
Study NCT ID: NCT07129018
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-19
First Post: 2025-08-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Trastuzumab Rezetecan Combined With Pertuzumab and Iparomlimab and Tuvonralimab for Biliary Tract Cancer
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module